Atara Biotherapeutics Inc (ATRA)
5.06
+20.19%
Atara Biotherapeutics Inc (ATRA) is currently trading at $5.06. This represents a gain of 20.19% from the previous session. With a market capitalization of $0.04B, ATRA is a key component of the Health Care sector. Investors looking to trade ATRA should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade ATRA commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Atara Biotherapeutics Inc (ATRA) shows a bullish trend. Analysts are watching the 5.56 level closely.
Fundamentals
Mkt Cap0.04B
P/E Ratio0.0000
Volume569,407
60-Day Technical Chart
Advanced Charting
Need more indicators for ATRA? Use the world's #1 platform.
Open ATRA on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $5
| Metric |
ATRA +20.19% |
OPEN -2.54% |
NIO -2.08% |
SNAP +2.01% |
|---|---|---|---|---|
| Price | $5.06 | $4.98 | $5.19 | $5.07 |
| Mkt Cap | $0.04B | $4.74B | $12.70B | $8.54B |
| - | View → | View → | View → |
Latest Headlines
$ATRA stock is up 16% today. Here's what we see in our data.
Quiver Quantitative • Feb 25, 2026
Atara jumps on FDA’s U-turn on cell therapy (ATRA:NASDAQ)
Seeking Alpha • Feb 25, 2026
Biotech Atara pushes $9M payment to 2028, grants 400,000-share warrant
Stock Titan • Feb 23, 2026
Atara Biotherapeutics stock plunges after FDA rejects cancer therapy
Investing.com • Jan 12, 2026
Atara Biotherapeutics Announces Third Quarter Financial Results and Operational Progress
Business Wire • Nov 12, 2025
● Gemini Agentic AI Analyst Insight for ATRA
Market Education
- Trump’s Latest Tariffs Send Shockwaves Across U.S. Economy Sep 26, 2025
- Every trader should read this handy guide- Tools & Reference Jul 15, 2023
- Finding Stocks in the Squeeze Zone: Using Finviz Jun 2, 2024
External Research